Copyright Reports & Markets. All rights reserved.

Global Hepatitis A Vaccination Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hepatitis A Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Inactivated Vaccine
    • 1.3.3 Live Attenuated Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hepatitis A Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Government Institution
    • 1.4.3 Private Sector
    • 1.4.4 Other
  • 1.5 Global Hepatitis A Vaccination Market Size & Forecast
    • 1.5.1 Global Hepatitis A Vaccination Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Hepatitis A Vaccination Sales Quantity (2020-2031)
    • 1.5.3 Global Hepatitis A Vaccination Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Hepatitis A Vaccination Product and Services
    • 2.1.4 GSK Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Hepatitis A Vaccination Product and Services
    • 2.2.4 Merck Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Hepatitis A Vaccination Product and Services
    • 2.3.4 Sanofi Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Sinovac
    • 2.4.1 Sinovac Details
    • 2.4.2 Sinovac Major Business
    • 2.4.3 Sinovac Hepatitis A Vaccination Product and Services
    • 2.4.4 Sinovac Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sinovac Recent Developments/Updates
  • 2.5 Zhejiang Pukang
    • 2.5.1 Zhejiang Pukang Details
    • 2.5.2 Zhejiang Pukang Major Business
    • 2.5.3 Zhejiang Pukang Hepatitis A Vaccination Product and Services
    • 2.5.4 Zhejiang Pukang Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Zhejiang Pukang Recent Developments/Updates
  • 2.6 Changchun Institute of Biological
    • 2.6.1 Changchun Institute of Biological Details
    • 2.6.2 Changchun Institute of Biological Major Business
    • 2.6.3 Changchun Institute of Biological Hepatitis A Vaccination Product and Services
    • 2.6.4 Changchun Institute of Biological Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Changchun Institute of Biological Recent Developments/Updates
  • 2.7 KM Biologics
    • 2.7.1 KM Biologics Details
    • 2.7.2 KM Biologics Major Business
    • 2.7.3 KM Biologics Hepatitis A Vaccination Product and Services
    • 2.7.4 KM Biologics Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 KM Biologics Recent Developments/Updates
  • 2.8 IMBCAMS
    • 2.8.1 IMBCAMS Details
    • 2.8.2 IMBCAMS Major Business
    • 2.8.3 IMBCAMS Hepatitis A Vaccination Product and Services
    • 2.8.4 IMBCAMS Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 IMBCAMS Recent Developments/Updates
  • 2.9 AIM Vaccine
    • 2.9.1 AIM Vaccine Details
    • 2.9.2 AIM Vaccine Major Business
    • 2.9.3 AIM Vaccine Hepatitis A Vaccination Product and Services
    • 2.9.4 AIM Vaccine Hepatitis A Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 AIM Vaccine Recent Developments/Updates

3 Competitive Environment: Hepatitis A Vaccination by Manufacturer

  • 3.1 Global Hepatitis A Vaccination Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Hepatitis A Vaccination Revenue by Manufacturer (2020-2025)
  • 3.3 Global Hepatitis A Vaccination Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Hepatitis A Vaccination by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Hepatitis A Vaccination Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Hepatitis A Vaccination Manufacturer Market Share in 2024
  • 3.5 Hepatitis A Vaccination Market: Overall Company Footprint Analysis
    • 3.5.1 Hepatitis A Vaccination Market: Region Footprint
    • 3.5.2 Hepatitis A Vaccination Market: Company Product Type Footprint
    • 3.5.3 Hepatitis A Vaccination Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hepatitis A Vaccination Market Size by Region
    • 4.1.1 Global Hepatitis A Vaccination Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Hepatitis A Vaccination Consumption Value by Region (2020-2031)
    • 4.1.3 Global Hepatitis A Vaccination Average Price by Region (2020-2031)
  • 4.2 North America Hepatitis A Vaccination Consumption Value (2020-2031)
  • 4.3 Europe Hepatitis A Vaccination Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Hepatitis A Vaccination Consumption Value (2020-2031)
  • 4.5 South America Hepatitis A Vaccination Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Hepatitis A Vaccination Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Hepatitis A Vaccination Sales Quantity by Type (2020-2031)
  • 5.2 Global Hepatitis A Vaccination Consumption Value by Type (2020-2031)
  • 5.3 Global Hepatitis A Vaccination Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Hepatitis A Vaccination Sales Quantity by Application (2020-2031)
  • 6.2 Global Hepatitis A Vaccination Consumption Value by Application (2020-2031)
  • 6.3 Global Hepatitis A Vaccination Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Hepatitis A Vaccination Sales Quantity by Type (2020-2031)
  • 7.2 North America Hepatitis A Vaccination Sales Quantity by Application (2020-2031)
  • 7.3 North America Hepatitis A Vaccination Market Size by Country
    • 7.3.1 North America Hepatitis A Vaccination Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Hepatitis A Vaccination Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Hepatitis A Vaccination Sales Quantity by Type (2020-2031)
  • 8.2 Europe Hepatitis A Vaccination Sales Quantity by Application (2020-2031)
  • 8.3 Europe Hepatitis A Vaccination Market Size by Country
    • 8.3.1 Europe Hepatitis A Vaccination Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Hepatitis A Vaccination Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hepatitis A Vaccination Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Hepatitis A Vaccination Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Hepatitis A Vaccination Market Size by Region
    • 9.3.1 Asia-Pacific Hepatitis A Vaccination Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Hepatitis A Vaccination Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Hepatitis A Vaccination Sales Quantity by Type (2020-2031)
  • 10.2 South America Hepatitis A Vaccination Sales Quantity by Application (2020-2031)
  • 10.3 South America Hepatitis A Vaccination Market Size by Country
    • 10.3.1 South America Hepatitis A Vaccination Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Hepatitis A Vaccination Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hepatitis A Vaccination Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Hepatitis A Vaccination Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Hepatitis A Vaccination Market Size by Country
    • 11.3.1 Middle East & Africa Hepatitis A Vaccination Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Hepatitis A Vaccination Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Hepatitis A Vaccination Market Drivers
  • 12.2 Hepatitis A Vaccination Market Restraints
  • 12.3 Hepatitis A Vaccination Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hepatitis A Vaccination and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hepatitis A Vaccination
  • 13.3 Hepatitis A Vaccination Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hepatitis A Vaccination Typical Distributors
  • 14.3 Hepatitis A Vaccination Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hepatitis A Vaccination market size was valued at US$ 789 million in 2024 and is forecast to a readjusted size of USD 916 million by 2031 with a CAGR of 2.2% during review period.
    Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Hepatitis A Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hepatitis A Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Hepatitis A Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Hepatitis A Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Hepatitis A Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hepatitis A Vaccination
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hepatitis A Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, AIM Vaccine, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hepatitis A Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Inactivated Vaccine
    Live Attenuated Vaccine
    Market segment by Application
    Government Institution
    Private Sector
    Other
    Major players covered
    GSK
    Merck
    Sanofi
    Sinovac
    Zhejiang Pukang
    Changchun Institute of Biological
    KM Biologics
    IMBCAMS
    AIM Vaccine
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hepatitis A Vaccination product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hepatitis A Vaccination, with price, sales quantity, revenue, and global market share of Hepatitis A Vaccination from 2020 to 2025.
    Chapter 3, the Hepatitis A Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hepatitis A Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hepatitis A Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatitis A Vaccination.
    Chapter 14 and 15, to describe Hepatitis A Vaccination sales channel, distributors, customers, research findings and conclusion.

    Buy now